Clinical Trials Logo

Chronic Renal Disease clinical trials

View clinical trials related to Chronic Renal Disease.

Filter by:

NCT ID: NCT01964014 Completed - Clinical trials for Chronic Renal Disease

Once-a-day Immunosuppression(CISECON_a_day)

CISECON
Start date: October 2013
Phase: Phase 4
Study type: Interventional

The objective of this study is to assess the efficacy and safety and Immunosuppressant Therapy Barrier Scale (ITBS) of once daily immunosuppressant maintenance therapy in patients who had kidney transplantations earlier.

NCT ID: NCT01817322 Completed - Clinical trials for Chronic Renal Disease

Kidney Graft Function Under the Immunosuppression Strategies

MyLowCsA
Start date: June 2011
Phase: Phase 4
Study type: Interventional

To demonstrate that cyclosporine-sparing immunosuppressions with the standard dose of Enteric-Coated Mycophenolate Sodium would preserve renal graft function after transplantation without an increase of incidences of adverse events, such as biopsy confirmed acute rejection, local or systemic infections, and bone marrow suppression.

NCT ID: NCT01532297 Completed - Clinical trials for Chronic Renal Disease

Application of Citrate Dialysate in Chronic Haemodialysis

Start date: October 2011
Phase: N/A
Study type: Interventional

Study investigating the safety and efficacy of the citrate dialysis solution compared to standard acetate dialysis solution. Use of citrate dialysis solution is not associated with a clinically relevant development of adverse events. It is hypothesized that citrate dialysate may provide a local anticoagulation effect in the dialyser improving removal of uremic toxins.

NCT ID: NCT01098799 Completed - Clinical trials for Chronic Renal Disease

Urotensin II in Chronic Kidney Diseases and Kidney Transplants

Start date: April 2010
Phase: N/A
Study type: Observational

The investigators are planning to study the serum level of Urotensin II in chronic kidney disease patients, kidney transplants, and healthy controls.

NCT ID: NCT00962000 Completed - Clinical trials for Chronic Kidney Disease

Study of How the Dose of Dialysis is Affected by Dialysate Flow Rate

Start date: September 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to look at how the dose of dialysis is affected by the rate at which dialysate flows through the dialyzer. The dose of dialysis (Kt/V) will be determined by measuring blood levels of urea at the beginning and end of dialysis at two different dialysate flow rates.

NCT ID: NCT00636077 Completed - Clinical trials for Chronic Kidney Disease

Comparative Effects Of Dialysate Flow Rate And Membrane Packing On The Performance Of Dialyzers Used For Hemodialysis

Start date: February 2008
Phase: N/A
Study type: Interventional

The purposes of this study are to determine if the performance of a dialyzer depends on how tightly the hollow fiber membranes are packed in the housing of the dialyzer (the membrane packing density) and if that dependence is a function of the dialysate flow rate. The study will examine how efficiently three different sized molecules pass through a dialyzer membrane at different dialysate flow rates in dialyzers with different membrane packing densities. Transfer of urea, phosphorus and beta-2-microglobulin from blood to dialysate will be measured during clinical hemodialysis using four different dialyzers, each used at three different dialysate flow rates. The data derived from these measurements may provide insight into the importance of membrane packing density as a design parameter for hemodialyzers and if changing the membrane packing density might provide equivalent performance at a lower dialysate flow rate.

NCT ID: NCT00560014 Completed - Clinical trials for Chronic Renal Disease

Nutrient Levels Alter Transplant Outcome

Start date: September 1997
Phase: N/A
Study type: Interventional

The purpose of this study is to look at lipid profiles of plasma and RBC and amino acid profiles in plasma to determine if they are associated with allograft rejection, calcineurin inhibitor toxicity or new onset diabetes mellitus in renal transplant patients receiving dietary supplements with arginine and omega-3 fatty acids.